| Repeated administration of low-dose cisplatin in mice induces fibrosis CN Sharp, MA Doll, TV Dupre, PP Shah, M Subathra, D Siow, GE Arteel, ... American Journal of Physiology-Renal Physiology 310 (6), F560-F568, 2016 | 124 | 2016 |
| Developing better mouse models to study cisplatin-induced kidney injury CN Sharp, LJ Siskind American Journal of Physiology-Renal Physiology 313 (4), F835-F841, 2017 | 113 | 2017 |
| Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease CN Sharp, MA Doll, J Megyesi, GB Oropilla, LJ Beverly, LJ Siskind American Journal of Physiology-Renal Physiology 315 (1), F161-F172, 2018 | 77 | 2018 |
| Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury TV Dupre, MA Doll, PP Shah, CN Sharp, D Siow, J Megyesi, J Shayman, ... Journal of lipid research 58 (7), 1439-1452, 2017 | 45 | 2017 |
| C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury SM Sears, CN Sharp, A Krueger, GB Oropilla, D Saforo, MA Doll, ... American Journal of Physiology-Renal Physiology 319 (4), F674-F685, 2020 | 37 | 2020 |
| Suramin protects from cisplatin-induced acute kidney injury TV Dupre, MA Doll, PP Shah, CN Sharp, A Kiefer, MT Scherzer, ... American Journal of Physiology-Renal Physiology 310 (3), F248-F258, 2016 | 35 | 2016 |
| Polypharmacy: a healthcare conundrum with a pharmacogenetic solution CN Sharp, MW Linder, R Valdes Jr Critical reviews in clinical laboratory sciences 57 (3), 161-180, 2020 | 24 | 2020 |
| Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics and therapeutics A Lavasanifar, CN Sharp, EA Korte, T Yin, K Hosseinnejad, SA Jortani Clinica Chimica Acta 493, 52-62, 2019 | 22 | 2019 |
| Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration CN Sharp, M Doll, TV Dupre, LJ Beverly, LJ Siskind American Journal of Physiology-Renal Physiology 316 (1), F162-F172, 2019 | 21 | 2019 |
| Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury SM Sears, TV Dupre, PP Shah, DL Davis, MA Doll, CN Sharp, AA Vega, ... Journal of Lipid Research 63 (3), 2022 | 10 | 2022 |
| Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity A Orwick, SM Sears, CN Sharp, MA Doll, PP Shah, LJ Beverly, LJ Siskind American Journal of Physiology-Renal Physiology 324 (3), F287-F300, 2023 | 8 | 2023 |
| Verification of newly FDA-approved kappa and lambda free light chain assays on a previously untested platform P Muluhngwi, CN Sharp, N Pozzi, RJ Elin, SA Jortani Journal of Applied Laboratory Medicine 4 (3), 323-330, 2019 | 8 | 2019 |
| Renal Toxicology/Nephrotoxicity of Cisplatin and Other Chemotherapeutic Agents TV Dupre, CN Sharp, LJ Siskind Elsevier, 2018 | 5 | 2018 |
| A shared diagnostic stewardship approach toward improving autoimmune encephalopathy send-out testing utilization CN Sharp, A Fletcher, P Muluhngwi, J Snyder, MW Linder, SA Jortani The Journal of Applied Laboratory Medicine 6 (2), 387-396, 2021 | 4 | 2021 |
| ELISA-based detection of Open Reading Frame protein 1 in patients at risk of developing lung cancer CN Sharp, EA Korte, K Hosseinejad, J Pitman, A Lavasanifar, ... Clinica Chimica Acta 507, 1-6, 2020 | 4 | 2020 |
| Newborn Drug Screening: Differential Outcome Using Meconium Versus Umbilical Cord Tissue N Algahmdi, C Sharp, T Robinson, S Jortani American Journal of Clinical Pathology 154, S2-S3, 2020 | 1 | 2020 |
| Integration of an evidence-based algorithm for inpatient autoimmune and paraneoplastic neurologic syndrome autoantibody panel ordering practice to improve diagnostic evaluation … A Fletcher, C Sharp, M Sweeney Neurology 94 (15_supplement), 466, 2020 | 1 | 2020 |
| A Shared Diagnostic Stewardship Approach to Autoimmune Encephalopathy Send-Out Testing C Sharp, P Muluhngwi, A Fletcher, M Linder, J Snyder, S Jortani American Journal of Clinical Pathology 154 (Supplement_1), S2-S2, 2020 | | 2020 |
| Mechanism and Treatment of Renal Fibrosis: Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and … CN Sharp, M Doll, TV Dupre, LJ Beverly, LJ Siskind American Journal of Physiology-Renal Physiology 316 (1), F162, 2019 | | 2019 |
| Cisplatin Effects in Lung Adenocarcinoma-bearing Mice, Alone and in Combination with Erlotinib CN Sharp Toxicologic Pathology 46 (8), 1049-1050, 2018 | | 2018 |
